FOLD Chart
- 52-Week Range: $6.23 - $12.48
- Market Capitalization: $2.08B
- Short Percentage: 0%
- Target Price: $14.33
- Shares Outstanding: 280.16M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
FOLD released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Amicus Therapeutics to Present at the Bank of America 2022 Healthcare ConferenceGlobeNewsWire | May 4th
- Amicus Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022GlobeNewsWire | April 26th
- Amicus Therapeutics to Present at the Cowen 42nd Annual Health Care ConferenceGlobeNewsWire | March 1st
- Amicus Therapeutics' (FOLD) CEO John Crowley on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 24th
- Amicus Therapeutics to Announce Full-Year 2021 Financial Results on February 24, 2022GlobeNewsWire | February 10th
- Amicus Therapeutics Announces Presentations and Posters at the 18th Annual WORLDSymposium™ 2022GlobeNewsWire | February 7th
Company Info
Website: https://amicusrx.com
Address: 3675 Market Street, Philadelphia, PA, United States, 19104
Sector: Healthcare
Industry: Biotechnology
Full time employees: 496
Address: 3675 Market Street, Philadelphia, PA, United States, 19104
Sector: Healthcare
Industry: Biotechnology
Full time employees: 496
$FOLD Move up
let's buy
$FOLD we all speculate but nobody knows what going to happen.
$FOLD FYI - leaning bullish
$FOLD we going up from here
$FOLD Shorts are calling in all the favors
$FOLD prepare your cash to buy dip
$FOLD the price is wrong
$FOLD why spike ?
$FOLD love cooking these little bears on here
$FOLD more calls coming in